Clinical trial
A Single Arm, Long-term, Multicentre Observational Study to Evaluate Effectiveness of Pegcetacoplan Under Real World Conditions in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT05776472 is registered in ClinicalTrials.gov with Swedish Orphan Biovitrum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Arm, Long-term, Multicentre Observational Study to Evaluate Effectiveness of Pegcetacoplan Under Real World Conditions in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Lead sponsor
- Swedish Orphan Biovitrum
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 26, 2023
- Completion date
- August 15, 2029
- Enrollment
- 165 (actual)
- Sites
- 87
Conditions
As the registry lists them; a condition with its own page is linked.
paroxysmal nocturnal hemoglobinuria